M
Michael Bergman
Researcher at New York University
Publications - 176
Citations - 3798
Michael Bergman is an academic researcher from New York University. The author has contributed to research in topics: Diabetes mellitus & Prediabetes. The author has an hindex of 32, co-authored 154 publications receiving 3261 citations. Previous affiliations of Michael Bergman include Bristol-Myers Squibb & New York Medical College.
Papers
More filters
Journal ArticleDOI
Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
William V. Tamborlane,Raymond L. Hintz,Michael Bergman,Myron Genel,Philip Felig,Robert S. Sherwin +5 more
TL;DR: The data suggest that the improved insulin delivery or metabolic control increases somatomedin levels despite a decrease in growth hormone, and insulin-pump treatment may be useful in optimizing growth in diabetic children.
Journal ArticleDOI
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia
Olov Wiklund,Bo Angelin,Michael Bergman,Lars Berglund,Göran Bondjers,Anders Carlsson,T. Linden,Tatu A. Miettinen,Bengt Ödman,Sven Olof Olofsson,Inkeri Saarinen,Risto Sipilä,Per Sjöström,Bengt G. Kron,Hannu Vanhanen,Irma Wright +15 more
TL;DR: Co-administration of pravastatin and gemfibrozil combined the specific effects of the two drugs on lipoprotein concentrations and ratios; the combination may be useful in selected cases of combined hyperlipidemia; however, the routine use of combination therapy is not advisable.
Journal ArticleDOI
Definition of Prediabetes
TL;DR: There is considerable evidence that glucose levels lower than those meeting the current definition of prediabetes may also be associated with similar concerns, particularly in high-risk individuals in accordance with a continuous glycemic risk perspective.
Journal ArticleDOI
Novel biomarkers for prediabetes, diabetes, and associated complications
Brenda Dorcely,Karin Katz,Ram Jagannathan,Stephanie S. Chiang,Babajide Oluwadare,Ira J. Goldberg,Michael Bergman +6 more
TL;DR: Combining several biomarkers may more precisely identify those at high risk for developing prediabetes and subsequent progression to diabetes.
Journal ArticleDOI
IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease
TL;DR: The data indicate that the immunological alterations found in PD may be partially attributed to levodopa administration, and provide a further support for the interrelationship between the central nervous and immune system.